You ask a question on 2c CR and predict the US trial will commence in Q2 2023. IMO if we're heading for Q22023 trial, it assumes successful results in Phase1 trial. In that case, the CR will be way above current price. We may even get non dilutionary capital from a potential partner.
- Forums
- ASX - By Stock
- IBX
- [VIDEO] Imagion Biosystems (ASX:IBX) finds that diagnostic tech has potential to work on multiple cancers
[VIDEO] Imagion Biosystems (ASX:IBX) finds that diagnostic tech has potential to work on multiple cancers, page-42
Featured News
Add IBX (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.6¢ |
Change
-0.001(2.13%) |
Mkt cap ! $1.979M |
Open | High | Low | Value | Volume |
4.7¢ | 4.7¢ | 4.6¢ | $14.05K | 300.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 4.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.8¢ | 45938 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 0.045 |
1 | 70000 | 0.044 |
1 | 15000 | 0.043 |
3 | 265000 | 0.042 |
2 | 17560 | 0.041 |
Price($) | Vol. | No. |
---|---|---|
0.048 | 45938 | 2 |
0.052 | 20000 | 1 |
0.057 | 13574 | 1 |
0.060 | 10000 | 1 |
0.063 | 38873 | 1 |
Last trade - 13.42pm 11/11/2024 (20 minute delay) ? |
Featured News
IBX (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, MD & CEO
Charles Armstrong
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online